GlassScriptPhysician profile
Caroline Gibbons
NPI 1710168026
$6,021.58
in general payments reported to CMS, 2019-2025
21 companies · $589 in 2025
The $589 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $46.24 · 2022: $198 · 2023: $175 · 2024: $4,782 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,599 · Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,599.00 |
| Food and Beverage | $947.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,500.00 | 2024 | |
| Mayne Pharma Commercial LLC | $246.47 | 2022-2025 | |
| Abbvie INC. | $232.67 | 2019-2020 | |
| Astellas Pharma US INC | $207.43 | 2024-2025 | Veozah |
| Pacira Pharmaceuticals Incorporated | $172.08 | 2022-2025 | Exparel |
| Abbott Laboratories | $133.26 | 2023 | Proclaim |
| Biogen, INC. | $82.67 | 2025 | Zurzuvae |
| Pfizer INC. | $64.10 | 2024-2025 | |
| Corium, LLC | $48.78 | 2024 | Azstarys |
| Merck Sharp & Dohme LLC | $46.11 | 2022-2023 | M-M-R II, Gardasil 9, Vaqta |
| Coopersurgical, INC. | $42.92 | 2025 | Paragard T 380a |
| Millicent US INC | $39.35 | 2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $34.84 | 2025 | Gemtesa, Myfembree |
| Organon LLC | $32.50 | 2024-2025 | Nexplanon |
| Applied Medical Resources Corporation | $27.63 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $26.65 | 2024 | Ova1 |
| Avanos Medical | $22.07 | 2019 | |
| Hologic Sales and Service, LLC | $22.06 | 2025 | Aptima |
| Sanofi Pasteur INC. | $17.87 | 2022 | |
| Therapeuticsmd, INC. | $11.26 | 2019 | |
| Amgen INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Gibbons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.